Chromogranin A Polymorphisms Are Associated With Hypertensive Renal Disease-Reference-Cited by-同舟云学术

Chromogranin A Polymorphisms Are Associated With Hypertensive Renal Disease

Published:2008-01-30 Issue:3 Volume:19 Page:600-614
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Salem Rany M.,Cadman Peter E.,Chen Yuqing,Rao Fangwen,Wen Gen,Hamilton Bruce A.,Rana Brinda K.,Smith Douglas W.,Stridsberg Mats,Ward Harry J.,Mahata Manjula,Mahata Sushil K.,Bowden Donald W.,Hicks Pamela J.,Freedman Barry I.,Schork Nicholas J.,O'Connor Daniel T.

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference93 articles.

1. The Chromogranin–Secretogranin Family

2. Chromogranin A in Human Hypertension

3. Catecholamine storage vesicle protein expression in genetic hypertension

4. Both Rare and Common Polymorphisms Contribute Functional Variation at CHGA, a Regulator of Catecholamine Physiology

5. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma catestatin levels are related to metabolic parameters in patients with essential hypertension and type 2 diabetes mellitus;Heart and Vessels;2023-09-27

2. Role of Catestatin in the Cardiovascular System and Metabolic Disorders;Frontiers in Cardiovascular Medicine;2022-05-19

3. GENETIC POLYMORPHISMS 415 (T>C) (RS9658635) AND+87 (C>T) (RS7610) AND SERUM LEVEL OF CHROMOGRANIN A IN SUBJECTS WITH METABOLIC SYNDROME IN THE FARS ETHNIC GROUP;J PHYSIOL PHARMACOL;2022

4. Neuropeptide Y gene variants in obesity, dietary intake, blood pressure, lipid and glucose metabolism: A longitudinal birth cohort study;Peptides;2021-05

5. Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis;Biomolecules;2021-03-18